ASTRO Annual Meeting
October 23 - 26, 2022
Triplet State Technology presents at ASTRO Annual Meeting. Booth #1940. Related poster presentation L.M. Naumann, et al, Dosimetric Evaluation of Physical Radiation Delivery Limits of a Weak Magnetic Field Generator on GBM Dose Distributions. Poster #3205.
Third Party Testing and Confirmation
September 21, 2022
TST device submitted to Intertek, Inc. (Notified Body) Lake Forest CA for performance, safety, electromagnetic compatibility testing and certification.
FDA submission Preparation
April 1, 2022
User Manual preparation begun in anticipation of submission for FDA review.
MSC Final Assembly and Testing
March 16, 2022
Magnetic Coil Subsystem (MCS) received at HDA in Lake Forest, CA for final assembly and testing of fully functional device.
Hirschberg Foundation Grant Awarded
October 28, 2021
Hirschberg Foundation grant awarded to UCLA to support testing of human pancreatic cancer cell lines with Triplet State method.
MCS Trial Installation and Performance Documentation
october 10, 2021
Successful Magnetic Coil Subsystem (MCS) trial installation at UCLA. Device tested with mock patient installed LINAC. Mechanical and dosimetric performance documented.
Publication
May 2021
Proof of concept research published. Keisuke S. Iwamoto et al. Weak Magnetic Field Enhanced the Efficacy of Radiation Therapy. Advances in Radiation Oncology: 6.3 May 1, 2021
Preliminary Patient Treatment Planning Initiated
April 2021
UCLA at direction of Dan Low PhD undertakes treatment metrics analysis relevant to case selection and planning for clinical application studies of Triplet State Technology LLC method employing version 1.01 device.
Revised Version 1.01 Statement of Work
March 31, 2021
Revised Statement of Work signed by Triplet State Technology LLC and RadiaBeam Technology. Agreement anticipates July device delivery.
Console Design Parameters Accepted
January 15, 2021
Revised Triplet State Technology LLC design inputs and requirements submitted by Peter Knopp incorporating power supply and Hall probe modifications.
Preliminary Notified Body Presentation
October 13, 2020
Presentation of testing, EMC and safety checklists by Francisco Lazcon representing TUV at monthly Triplet State Technology LLC management meeting.
Business Plan Finalized
August 30, 2020
Cesira, Inc. and Triplet State Technology, LLC finalize business plan.
Engineering Chief Added
March 29, 2020
Peter Knopp BEng, MS joins Triplet State Technology LLC as director of engineering. Will manage design and manufacture of version 1 device and coordinate regulatory management.
Triplet State Technology LLC Funds Cancer Research
February 7, 2020
Triplet State Technology LLC funds additional cell culture and animal implant studies of combined magnetic and radiation treatment of pancreatic adenocarcinoma. Will introduce pancreatic and intestinal Organoids culture methods at direction of Kei Iwamoto PhD.
Triplet State Technology LLC Represented at ESTRO Asia Pacific
December 6-9, 2019
Dr. Sandstrom represents Triplet State Technology LLC at ESTRO Asia Pacific. Participant seminar regarding proton beam radiation biophysics. Secondary radical pair mechanism discussed as a component of proton radiation effect.
Design Revision
November 2019
RadiaBeam Technology submits revised design for patient treatment module.
Clinical Treatment Device Contract Signed
0ctober 14, 2019
Research Design and Build contract signed with RadiaBeam Technology, Santa Monica, California.
Notified Body Consideration
September 2019
Triplet State Technology LLC and TUV Rheinland undertake discussions regarding device testing at TUV laboratories as a component of FDA submission and CE mark clearance step.
Contract for Business Plan Review
July 2019
Contract signed with Cesira Inc, Encinitas California for business modeling and valuation and business planning. Principals: Marilyn Ferrari PhD. M.B.A, Randy Schreckise BS (Molecular Biology), MBA.
Clinical Study Planning
March 2019
Preliminary Clinical study design and budget discussed with Mr. Vincent Basehart, Director for Clinical Research UCLA Dept of Radiation Oncology.
First Design Draft
February 2019
Preliminary engineering design draft for clinical device submitted by RadiaBeam Technology engineering group.
User Design Safety
January 2019
User design and device safety analysis submitted by Triplet State Technology LLC design committee.
Initial Device Design Draft
January 2019
Draft design requirements for Triplet State Technology LLC clinical device adopted and submitted to RadiaBeam Technology engineering group for build out planning.
60th Annual ASTRO Meeting
October 2018
Dr. Sandstrom represents Triplet State Technology LLC at ASTRO meeting in Atlanta. Consultation with Robert Morton.
Quality and Regulatory Services
October 2018
Contract signed with RadiaBeam Technology for Quality and Regulatory Services. Principal, Ronald Decker.
Linda Strause PhD Joins Executive Team
October 2017
Linda Strause PhD, Principal Strategic Clinical Consultants, joins Triplet State Technology LLC executive management.
Quality and Regulatory Services Agreement
November 9, 2017
Triplet State Technology LLC finalizes a consulting agreement with Robert J. Morton, M.S., consulting medical physicist and president of Quality & Regulatory Services of Lincoln CA to assist Triplet State in FDA market clearance of their device to include 510K submission and 510K approval.
Strategic Clinical Consultants Agreement
SEPTEMBER 30, 2017
Contract agreement with Strategic Clinical Consultants of San Diego, CA to manage clinical testing and trials in conjunction with UCLA Department of Radiation Oncology. Linda Strause, PhD, principal and founder of Strategic Clinical Consultants brings to the project a depth of experience in clinical trials management and FDA regulatory requirements.
RadiaBeam Technology Contract
AUGUST 3, 2017
Contract with RadiaBeam Technologies, Santa Monica CA, to design and manufacture prototype device with and for Triplet State Technologies for human trials was signed today.
Jlabs Meeting
march 7, 2017
Dr. Sandstrom represents Triplet State Technology at Jlabs meeting on The Value of a Biotechnology Business in San Francisco, CA
Jlabs Meeting
February 21, 2017
Dr. Sandstrom represents Triplet State Technology at Jlabs meeting on Technology Start Up Board and Governance Structure in San Francisco, CA
54th Annual ASTRO Meeting
October 28, 2012
Triplet State Technology and the UCLA scientific team present preliminary research findings at the American Society for Radiation Oncology (ASTRO) meeting in Boston, MA